Medtronic plc.

Open: 85.15 Close: 85.95 Change: 0.8

Can you guess what an AI found about Medtronic plc..

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, MDT, share, company, dividend, Medtronics, stock, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Polen International Growth Strategy featured stocks like Medtronic plc (NYSE: MDT ) in the fourth quarter 2023 investor letter. Board authorizes $5 billion for share repurchases, consistent with its history of increasing dividends for 46 years. In the past six months, Medtronics shares have gained 6.9% compared with the industry s rise of 11% Zacks Rank #3 (Hold)

Today's News

Polen International Growth Strategy featured stocks like Medtronic plc (NYSE: MDT ) in the fourth quarter 2023 investor letter. Polen: Medtronic shares trading at their lowest valuation in a decade New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management. Board authorizes $5 billion for share repurchasing. Medtronic board authorizes $5 billion for share repurchases, consistent with its history of increasing dividends for 46 years. In the past six months, Medtronics shares have gained 6.9% compared with the industry s rise of 11% Zacks Rank #3 (Hold) Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 46 consecutive years. The dividend of $0.69 per share will be payable on April 12, 2024. Medtronic will participate in the 26th annual Barclays global healthcare conference on March 12, 2024. A live webcast of the Q&A session will be available on the event link at http://investorrelations.com. Medtronic once again named one of the worlds most ethical companies. CSRwire: Medtronics once again Named One of the Worlds Most Ethical Companies. Prosthetic cardiac valves was a key innovation area identified from patents. Medtronic PLC (MDT) is a global developer and manufacturer of medical devices for chronic diseases. Founded in 1949, Medtronics is now a $111 billion (by market cap) healthcare behemoth that employs 95,000 people. To date, the company has increased its dividend for 46 consecutive years. Medtronic PLC (MDT) i s a great healthcare business benefiting from favorable demographic trends, secular growth, and pent-up demand. Since the big acquisition and the pandemic, Medtronics has been struggling. Medtronic is the 129th most valuable company by market cap according to our data. The company manufactures more than half of all pacemakers. Medtronic plc (NYSE:MDT) announced strong quarterly results and raised its full-year outlook. MDT : 85.99 (+0.57%) DXCM : 136.31 (+2.46%) Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI. The expert summary provides a deeper understanding of how each news could potentially affect Medtronic Plcs stock performance. FDA Clears Medtronic Affera EP Mapping System, moving company closer to a US launch for the Affera mapping and cardiac ablation system, which also includes the Sphere-9 ablation catheter. Wall Street analysts consensus recommendation is to buy Medtronic stock. The consensus analyst rating on MDT is a Buy. WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, MDT, share, company, dividend, Medtronics, stock, and the most common words in the summary are: medtronic, stock, mdt, market, news, plc, company, . One of the sentences in the summary was: Board authorizes $5 billion for share repurchases, consistent with its history of increasing dividends for 46 years. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #mdt #market #news #plc #company.